Sentences with phrase «regulatory health law issues»
Not exact matches
Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 10 - Q.
https://www.cnbc.com/
About Blog Covering emerging and new developments in health law, health care reform, privacy issues, and regulatory and compliance matters.
Her practice includes medical malpractice defense and health law issues, including board investigation defense and regulatory compliance.
The specialist regulatory team at Harrison Clark Rickerbys has been strengthened by the arrival of partner Peter James, whose extensive experience of handling health and safety issues and environmental law will broaden the team's skills.
He is an experienced regulatory law practitioner and specialises in advising professional associations, professionals and insurers on regulatory issues, public law, fitness to practise, health and safety investigations, prosecutions and data protection, and cyber risk.
They include: (1) regulatory law and enforcement work, because industries from banking to private equity funds to large oil companies will likely be targets of the new administration, while health insurance companies will be subject to heightened regulation; (2) litigation, because a Democratic administration will probably push back tort reform measures, giving rise to more lawsuits; (3) «green» law, i.e., representing companies that deal in green technology, whose growth will be stimulated by likely tax incentives as well as a cap and trade system; and (4) real estate, because the bailout legislation will most likely require banks availing themselves of the benefits to begin issuing mortgages again.
Ms. Boyle regularly advises health care providers on the myriad regulatory issues they face, such as compliance with the Stark law, the anti-kickback statute, and the Emergency Medical Treatment and Labor Act (EMTALA); gainsharing; medical staff and peer review; clinical integration, physician recruitment, and compensation; medical staff bylaws; management arrangements; and electronic medical records.
Mr. Wasserman has represented a diverse group of health care providers and entities including hospitals, hospital medical staffs, long - term care facilities, physicians, physician specialty organizations, and other health - related entities in matters of health and hospital law, including, without limitation: the analysis of health care fraud and abuse matters, JCAHO matters, reimbursement issues, tax - exempt issues, and other corporate compliance and federal and state regulatory matters.
John consults as a subject matter expert and provider legal backup to other attorneys and law firms from around the country on specialized compliance, regulatory and health care issues.
Our project teams are multidisciplinary and include lawyers that are intimately familiar with the many issues and disciplines involved in a pipeline project, including the following: tax; project development; business organization; relevant regulatory regimes; health, safety and environmental commitments; business competition laws; and project finance.
We also advise on the legal issues that frequently arise from breaches such as data protection, employment law, intellectual property / confidential information, regulatory, insurance, health & safety and product liability.
Runner - up: Rosen Sunshine LLP Blog: This Toronto health law boutique's blog is remarkably prolific, covering a range of health law topics from regulatory issues to legislation to front - page news stories.
He also advises health care providers on state and federal regulatory issues, including COPN, licensure and the Stark Law.
Advised an international oil and gas corporation on the launch of a new product, focusing particularly on product liability, health and safety, regulatory law and general contract and tort issues.
For Leslie Dunlop, vice president and corporate counsel at Bioniche Life Sciences Inc., a publicly traded, Belleville, Ont. - based biopharmaceutical company that «discovers, develops, manufactures, and markets proprietary products for human and animal health markets,» a constant issue for her and her company is adhering to the many regulatory requirements of securities law, including the obligation to disclose material information in a timely way.
He practises regulatory and intellectual property law, with a focus on food, nutraceutical (natural health product / dietary supplement), drug and other regulatory issues, as well as related litigation.
About Blog Covering emerging and new developments in health law, health care reform, privacy issues, and regulatory and compliance matters.
About Blog Covering emerging and new developments in health law, health care reform, privacy issues, and regulatory and compliance matters.